TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Aprea Therapeutics AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
128
|
120 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-3,622
|
-41,381
|
-81,134 |
| EBITDA |
-3,803
|
-41,366
|
-83,064 |
| Total assets |
11,756
|
11,935
|
44,147 |
| Current assets |
11,685
|
11,864
|
43,979 |
| Current liabilities |
5,363
|
6,354
|
31,182 |
| Equity capital |
6,393
|
5,581
|
12,175 |
| - share capital |
6,393
|
6,360
|
6,921 |
| Employees (average) |
1
|
6
|
9 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
54.4%
|
46.8%
|
27.6% |
| Turnover per employee |
0
|
21
|
13 |
| Profit as a percentage of turnover |
-32328.9%
|
-67611.7% | |
| Return on assets (ROA) |
-30.8%
|
-346.7%
|
-183.8% |
| Current ratio |
217.9%
|
186.7%
|
141.0% |
| Return on equity (ROE) |
-56.7%
|
-741.5%
|
-666.4% |
| Change turnover |
-128
|
17
|
4 |
| Change turnover % |
-100%
|
16%
|
4% |
| Chg. No. of employees |
-5
|
-3
|
0 |
| Chg. No. of employees % |
-83%
|
-33%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.